Related Experiment Videos
Methods for assessing drug-related anticholinergic activity.
Kelly M Rudd1, Cynthia L Raehl, C A Bond
1Section of Clinical Pharmacology, Department of Pharmaceutical Care Services, Bassett Healthcare, Cooperstown, New York 13326, USA. kelly.rudd@bassett.org
Pharmacotherapy
|October 20, 2005
Summary
Elderly patients often take multiple medications, increasing risks from anticholinergic drugs. Clinicians aim to reduce exposure, but only one of four reviewed methods is clinically practical for managing these drug effects.
Area of Science:
- Geriatric Pharmacology
- Clinical Pharmacy
- Drug Safety
Background:
- The geriatric population extensively uses prescription and over-the-counter medications.
- Polypharmacy in elderly individuals complicates the balance between therapeutic benefits and adverse drug events.
- Increased sensitivity to drug effects in older adults heightens concerns, particularly regarding anticholinergic properties.
Purpose of the Study:
- To review and identify systematic methods for reducing or eliminating anticholinergic drug exposure in geriatric patients.
- To evaluate the clinical utility and research applicability of identified strategies for managing anticholinergic burden.
Main Methods:
- A comprehensive literature review was conducted to identify approaches for minimizing anticholinergic medication use in the elderly.
- Four distinct methods were identified and analyzed for their potential to reduce adverse drug events.
Main Results:
- No single ideal evidence-based approach was found to systematically reduce anticholinergic drug use.
- Three of the four reviewed methods demonstrated research utility.
- Only one of the four identified methods was deemed clinically useful for practical application by healthcare providers.
Conclusions:
- Minimizing anticholinergic drug exposure is crucial for geriatric patient safety.
- Current literature offers limited clinically practical strategies, with only one method showing direct applicability.
- Further development of evidence-based, clinically useful approaches is needed to manage anticholinergic medication risks in the elderly.